ArticleMedical science monitor : international medical journal of experimental and clinical research2020

Olmutinib Reverses Doxorubicin Resistance in ETS1-Overexpressing Leukemia Cells.

Jiansheng Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.